Palisade Bio, Inc. Share Price
PALIPalisade Bio, Inc. Stock Performance
Open $1.70 | Prev. Close $1.83 | Circuit Range N/A |
Day Range $1.70 - $1.85 | Year Range $0.53 - $3.30 | Volume 1,67,736 |
Average Traded $1.78 |
Palisade Bio, Inc. Share Price Chart
About Palisade Bio, Inc.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.
Palisade Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $1.70 | $1.78 | +0.00% |
04-Dec-25 | $1.70 | $1.78 | -2.46% |
02-Dec-25 | $1.89 | $1.83 | -1.35% |
01-Dec-25 | $2.03 | $1.85 | -11.88% |
28-Nov-25 | $2.13 | $2.10 | -5.18% |
26-Nov-25 | $2.15 | $2.22 | +3.26% |
25-Nov-25 | $2.29 | $2.15 | -5.29% |
FAQs on Palisade Bio, Inc. Share Price
Can I buy Palisade Bio, Inc. shares in India?
What is the share price of Palisade Bio, Inc.?
What is the 5 year returns of Palisade Bio, Inc.?
What are the high & low stock price of Palisade Bio, Inc. today?
What is the 52-week high and low of Palisade Bio, Inc. stock?